1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Aflibercept and Bevacizumab for Diabetic MaculopathiesDiabetic MaculopathyRecruitingPhase 42025-09-19NCT06850571